The pharmaceutical industry confronts a pressing challenge: achieving the optimal balance between expedited drug development and environmentally responsible practices. While the need for swift discoveries to address global health challenges is undeniable, it's crucial to mitigate the industry's carbon emissions. This delicate equilibrium demands a